pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1199 |
Genomic Coordinates | chr19: 14073361 - 14073479 |
Description | Homo sapiens miR-1199 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1199-5p | |||||||||||||||||||||
Sequence | 21| CCUGAGCCCGGGCCGCGCAG |40 | |||||||||||||||||||||
Evidence | Not_experimental | |||||||||||||||||||||
Experiments | ||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TP53INP2 | ||||||||||||||||||||
Synonyms | C20orf110, DOR, PIG-U, PIGU, PINH, dJ1181N3.1 | ||||||||||||||||||||
Description | tumor protein p53 inducible nuclear protein 2 | ||||||||||||||||||||
Transcript | NM_021202 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TP53INP2 | |||||||||||||||||||||
3'UTR of TP53INP2 (miRNA target sites are highlighted) |
>TP53INP2|NM_021202|3'UTR 1 GCGTCCACCGGCCGCGCCACGAACCCCTTGCCGATCCCGATCCCTGTCGGGCTCCTCCGACTCCTCGGGCTGGACACCGA 81 AACCTCCCTTCTTAAAGCGTGTGAGGTTGGGTGATAGCCGTTCCTTCCCCGACACCCTCAATTTCCCCATCTCTGATCCT 161 CTAATCTGCCTCTGAACCCATTCACCCTTCACCCTCACTCCTGGTCCCCATACCCAGCATCTAATCATCCATGCCCCCTA 241 CTCCTGGCCCCTCCATCCTTTCTTCTCTGGTCCCCATCCCTGTCTCTCCCTTTCACCCTTGCCCTCCAGTCCTCTACCTC 321 TGGCCTGCCCCTATTTCTGAAAGCTTCTTCCAGTCCCTGATCTGGCTCATTCCCCACCTTCAACTCCCACCTTACATGTC 401 TCACACTATCCCATGGTTGGCATTACACTCACTCCTGTTCCCTTATTCTTCATTCCCAGTAATTCCCTACCAAATGGTGG 481 GGACCCTGAGCCCAGCTCTGACCAGGTAGAGCCTGTGCAGCCTGGGCTGCTGTCATTGCCCTCCAGTAAGGGCTCAGGGT 561 TTTGCTTTTAGTCTCCCCTTCCTTCTGCCTTGGGGGCGGTACTCTGTGGAGCTGCTTAGGCCTGGAAAGGTACAGTATGT 641 AGAAGAGGACTGTGAGACGTGAGTTAGAGGGAGAAGATGGAGGGAATCTAGGGAACGAGGCAGCCTATTGGAGATGCGGA 721 CAGGACAGACACGTTGAGAAGCTGCAGGGAGCAGGGCACCAAGGGAGTGTGCACTGTGCTTGCTCAGAGAGGCCAAACCC 801 TGCTCCCAGGCTGAAGCCTGGAGTCTGCCCCCACTTCCCTTTTCTATAATCCACCCTTCTGCAGGCCCTGAAATCTGAAG 881 GGCTTAGTTAGTACCTTGCCACTCTACCCCCAACACGTCACCCGAGTAGAAGCTGGGCAAGGCCCTACCATCCTGGCCGT 961 CTGTTCACAAGCCCAAGGTGCTAGAACTAGCTTAGGAGACATGCAGGCCACAGGGCTTCTAGGCAGGGAAAGGGCACACA 1041 CCCTAGGTCAGCGTGCAGAGCAGTGATGCTGGAGGACACACCATGGGGTGAAGCCATCCCAAGGCTGACAGCTCAGTCTT 1121 CACCTTGCCTCTGGCCTTGTATTTCACACCCTGCTCAGTATGGCTAGCCAGCAGTCCTGAGTAGGAGTCCAGGACTCCCA 1201 CTGTCTCAATCTGCAAATTGTTCCTATCCAGGTTCAGGGCCTTCAGGGGGCCTCTTTTCATTTTCTCCCACAGGCCTCTC 1281 TTTCTTTCTAGGTTGCTGGGGAGAAATGGGTACCCTATGATCCCCCTCCCCTTCTCCTCCAGTAAATACCTGGAAGAGGG 1361 AACCTGAATCCCTGGGGGAGACAGAAGGGGCAGGGGCCACCAGCCTCCCCTTCTTGTGGTGAGACTGAATTTTGGGCTCA 1441 GACACCAGCAACAGCCTCTTGGGATGCCCTGAGTTGCTTCCCATTTCCTCTTTCTAGCCGTCCTTTTCTAGTGTGTGCTC 1521 ACTCTTCCTAGGAACTTTTAAGACTTCTTGGTACCTATGAACATAGGTCCTCCCCTCACCCCAACTCTAGGTTTCCAGGC 1601 CTCACAGCCAAGCTGAAGCTTGGAGAAAACTCTGCATTCCCATGAGGGCAAAGGCAGCTGCCCTCCCTGACCCTATAGCC 1681 CCAGGCCTCATGGGGGGTATGTGGGGAAGGGATGGGGTATCCCCATGGATGCTGGGATGAGGACAGAGGAAGACCTGATG 1761 GGGTCTCCTATTCCAGGGAATAAGCCAAATTAACACTAAAAACGGATCAAAGCTCCCACGCCAGTCCACTAGGGCCCCAG 1841 TAGTTGACAGCCTTGCTCCTCTCCCAAGTTCTCCTTCAGAACCTAGTTGCTTTTATTCTTCCAGCTACCACTTGGGCACT 1921 TCACAGCCAGCCTAGGGTCTTCGGCACCTCCAAGAGCTGAATCTCCCTCCAACCCTTCTTGCCTACTCCTCACTGCCAGC 2001 TGGGACCTAGGCTCAGTCCTGTGTGGTGCCCATGATCCTTCTGGTGGGGGAAGAGTTTAAGTTATAGGGCATTTGGCTCA 2081 AATTTTAAAAGGCCTTTTGTTTACCTATATTTCTGGAGGCTCCTGTATTCTAGAACCCAATCTCTCACCTGCTTGGTTGC 2161 AAGGCTCATATTTTTTTGTACCTTTCCTATAGATTCTGTAGCATTTGAGTGTGGCAATATTTTAATTGTGTATAGATTTC 2241 TAAGAACCAACACTACTCAGTCTCCTGCTAGTCTGACTCCTGAAGCATCAGCCCTTGTCATACTGTATTGACTGTGTACG 2321 TGCCTTTCACCTTGAGCATGCTTCAGGATTTTTTTTTAAACCACAGAACTTGAATACATGAGGGAACCAGAGTTCAAAGT 2401 CCTATGCAACCTTAGGAGGGGGTTAGAGAGTCTGTTTTGATTGATGTTTTCTGAGGCCCTAGAGGAGTTTGTATCAATTT 2481 GTGAGTATTAATGTCAGTACTACCAGCACTTTGCCAAAACTGTCAGAGGGACCCGTTTCTAGAGTGAGTCCCAGTTACAT 2561 CAAACAGTGACTTCCAGTTATTCCCCAGTAAGTCTGAGTGGTTCCTTCAAGCTGGGTGTCTTTCCAGCCTTTGCCAGTCT 2641 AGCCCCAGCAGGGCACCGTGTATGAATGCAGTTTGGTGCTGTTTTAGAGTATGCCTGCTCCCCAGCCCCCTGCCTGGAAC 2721 CCTCTGAGCAACTTGCTCTGACCTATAATGTCTTAGGTGCAACACGGACCCCACCAGAGCTCTTGGATACCCCCCTAGAT 2801 CCATGTGGCTTTATGTGAGGGGACTGAATGCAGACACACCATAGCCCCCTTCTACTACTTTCCCTCTCGCCCTGCCACCT 2881 AGTTCCACATGGAACCAACAAGTTGAGTGCATCCCTGTTGGGTGTTTTGTGTTGAGACTGGCTGAAATGAGGAGACTTTG 2961 ACCATGTGACGTGTCAACAGACTCAAGGAGACAACCACCTCAACTGGGTCATGTGGCATGCCTGTGTATGTGTGTAACAG 3041 AATTCTGATTGTTAGACTGTAATGCTATTCCTCTATGGGAGAAAAAAATTAATATAAAGAAAAACAAATAAAAATATATT 3121 TAAAGCACATGAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 58476.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760639. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_A
PAR-CLIP data was present in SRX1760641. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP-MDV_B
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000374810.3 | 3UTR | UUGGGCUCAGACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
75 hsa-miR-1199-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT130735 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 4 | ||||||||
MIRT134908 | CCND2 | cyclin D2 | 2 | 2 | ||||||||
MIRT273033 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT276644 | KPNA3 | karyopherin subunit alpha 3 | 2 | 6 | ||||||||
MIRT446532 | OAS2 | 2'-5'-oligoadenylate synthetase 2 | 2 | 2 | ||||||||
MIRT456270 | TDRKH | tudor and KH domain containing | 2 | 12 | ||||||||
MIRT494455 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT494966 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT496690 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 2 | ||||||||
MIRT496698 | RGS11 | regulator of G protein signaling 11 | 2 | 2 | ||||||||
MIRT504377 | IRF4 | interferon regulatory factor 4 | 2 | 6 | ||||||||
MIRT510981 | PFN2 | profilin 2 | 2 | 6 | ||||||||
MIRT512549 | MFN2 | mitofusin 2 | 2 | 6 | ||||||||
MIRT513640 | TP53INP2 | tumor protein p53 inducible nuclear protein 2 | 2 | 2 | ||||||||
MIRT514017 | CAMSAP1 | calmodulin regulated spectrin associated protein 1 | 2 | 4 | ||||||||
MIRT514075 | MTRNR2L6 | MT-RNR2-like 6 | 2 | 2 | ||||||||
MIRT515302 | C15orf38-AP3S2 | C15orf38-AP3S2 readthrough | 2 | 4 | ||||||||
MIRT517286 | AP3S2 | adaptor related protein complex 3 sigma 2 subunit | 2 | 4 | ||||||||
MIRT519076 | KCNK6 | potassium two pore domain channel subfamily K member 6 | 2 | 2 | ||||||||
MIRT520780 | TCF23 | transcription factor 23 | 2 | 2 | ||||||||
MIRT522487 | MFSD9 | major facilitator superfamily domain containing 9 | 2 | 2 | ||||||||
MIRT528857 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT529080 | PATE2 | prostate and testis expressed 2 | 2 | 2 | ||||||||
MIRT531210 | PLA2G4D | phospholipase A2 group IVD | 2 | 2 | ||||||||
MIRT533989 | TAB3 | TGF-beta activated kinase 1 and MAP3K7 binding protein 3 | 2 | 2 | ||||||||
MIRT537025 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT537499 | FAM168B | family with sequence similarity 168 member B | 2 | 2 | ||||||||
MIRT553127 | UBE2Z | ubiquitin conjugating enzyme E2 Z | 2 | 2 | ||||||||
MIRT555592 | PIP5K1C | phosphatidylinositol-4-phosphate 5-kinase type 1 gamma | 2 | 2 | ||||||||
MIRT556371 | LUZP1 | leucine zipper protein 1 | 2 | 2 | ||||||||
MIRT569746 | C2orf71 | chromosome 2 open reading frame 71 | 2 | 2 | ||||||||
MIRT570150 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT571244 | FADS6 | fatty acid desaturase 6 | 2 | 2 | ||||||||
MIRT573066 | TRIB1 | tribbles pseudokinase 1 | 2 | 2 | ||||||||
MIRT575534 | Map4 | microtubule-associated protein 4 | 2 | 2 | ||||||||
MIRT575778 | Tnfrsf10b | tumor necrosis factor receptor superfamily, member 10b | 2 | 2 | ||||||||
MIRT616559 | ZNF512B | zinc finger protein 512B | 2 | 2 | ||||||||
MIRT630079 | GRWD1 | glutamate rich WD repeat containing 1 | 2 | 2 | ||||||||
MIRT631480 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT632174 | CCL22 | C-C motif chemokine ligand 22 | 2 | 2 | ||||||||
MIRT638398 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT641193 | ISG20L2 | interferon stimulated exonuclease gene 20 like 2 | 2 | 2 | ||||||||
MIRT642563 | TEX9 | testis expressed 9 | 2 | 2 | ||||||||
MIRT642938 | KRTAP5-9 | keratin associated protein 5-9 | 2 | 2 | ||||||||
MIRT649704 | ZNF175 | zinc finger protein 175 | 2 | 2 | ||||||||
MIRT652114 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT652274 | TOMM20 | translocase of outer mitochondrial membrane 20 | 2 | 2 | ||||||||
MIRT655216 | PFKM | phosphofructokinase, muscle | 2 | 2 | ||||||||
MIRT682779 | ZNF852 | zinc finger protein 852 | 2 | 2 | ||||||||
MIRT683002 | MUC20 | mucin 20, cell surface associated | 2 | 2 | ||||||||
MIRT684321 | GTF3C4 | general transcription factor IIIC subunit 4 | 2 | 2 | ||||||||
MIRT689436 | CYB561 | cytochrome b561 | 2 | 2 | ||||||||
MIRT693848 | ZNF107 | zinc finger protein 107 | 2 | 2 | ||||||||
MIRT696716 | TAX1BP3 | Tax1 binding protein 3 | 2 | 2 | ||||||||
MIRT698598 | TEX261 | testis expressed 261 | 2 | 2 | ||||||||
MIRT699974 | RREB1 | ras responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT703311 | GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT706797 | RAI1 | retinoic acid induced 1 | 2 | 2 | ||||||||
MIRT709005 | CD109 | CD109 molecule | 2 | 2 | ||||||||
MIRT709182 | TBC1D10B | TBC1 domain family member 10B | 2 | 2 | ||||||||
MIRT709836 | PAQR7 | progestin and adipoQ receptor family member 7 | 2 | 2 | ||||||||
MIRT711628 | CORO1C | coronin 1C | 2 | 2 | ||||||||
MIRT712635 | RNF103-CHMP3 | RNF103-CHMP3 readthrough | 2 | 2 | ||||||||
MIRT713695 | CYB5R4 | cytochrome b5 reductase 4 | 2 | 2 | ||||||||
MIRT713753 | SLC9A8 | solute carrier family 9 member A8 | 2 | 2 | ||||||||
MIRT714909 | CHMP3 | charged multivesicular body protein 3 | 2 | 2 | ||||||||
MIRT716372 | CBLL1 | Cbl proto-oncogene like 1 | 2 | 2 | ||||||||
MIRT718304 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT718714 | ANKRD18A | ankyrin repeat domain 18A | 2 | 2 | ||||||||
MIRT718741 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT719442 | NPTX2 | neuronal pentraxin 2 | 2 | 2 | ||||||||
MIRT720897 | OTUD4 | OTU deubiquitinase 4 | 2 | 2 | ||||||||
MIRT722450 | RXFP4 | relaxin/insulin like family peptide receptor 4 | 2 | 2 | ||||||||
MIRT723883 | VKORC1 | vitamin K epoxide reductase complex subunit 1 | 2 | 2 | ||||||||
MIRT724587 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|